Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.

BMC Cancer · 2023 · PMC10668510 · PMID 37996813

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Patients with male,N3 disease and EGFR expression (+ + / + + +) also showed a favorable trend in terms of survival benefits.

also in 887 other papers

an increasing trendno p-value reported

Additionally, an increasing trend was observed in progression-free survival, and the incidence of side effects was similar in both groups.

also in 32,554 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.